Risk-Based Identity Testing of Raw Materials in Gene Therapy Manufacturing

Download our ASGCT 2025 Poster

‍Get exclusive access to our ASGCT 2025 poster! Enter your email to download the poster and stay informed on how we’re pushing the boundaries of cell and gene therapy for a better future.

‍

Inside you’ll learn:

• Key regulatory requirements (FDA, ICH)
• Risk-based decision tree for testing strategies
• Case examples with cost-saving outcomes
• Additional methods like amino acid analysis and CoA verification